November 25, 2019 Live Varicella Vaccine Is Safe and Effective in Patients Taking TNF Inhibitors The safety of live virus vaccines in patients receiving biologic therapies was confirmed in a study of 617 patients recently presented at the American College of Rheumatology annual meeting this month. Learn more   Study Shows Promise in Immunotherapy for Rheumatoid Arthritis Researchers are exploring the possibility of using immune checkpoint inhibitors in rheumatoid arthritis patients. A small study presented at the American College of Rheumatology (ACR) annual meeting earlier this month shows that rheumatoid arthritis (RA) patients who were treated with immunotherapy, responded just as well as a comparable patient population with only 12 of 22 patients experiencing flares.. Learn more   Senior Rheumatoid Arthritis Patients May Be Missing Out on Treatments Even though senior patients with rheumatoid arthritis receive biologic therapies less often than patients who develop the condition early in life, a Japanese study presented this month at the ACR annual meeting, shows that patients 60 years and older can benefit from therapy just as much as younger patients. Learn more